Lasa Supergenerics Company Description

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India.

It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, and halquinol, as well as 2,6-diiodo-4-nitrophenol; and other API products.

The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide.

In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.

Lasa Supergenerics Limited

Country	India
Founded	2016
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	77
CEO	Omkar Herlekar

Contact Details

Address: Plot no. C-4 Ratnagiri, 415722 India
Phone	91 96 0797 3801
Website	lasalabs.com

Stock Details

Ticker Symbol	LASA
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE670X01014
SIC Code	2833

Key Executives

Name	Position
Dr. Omkar Pravin Herlekar	Chairman and MD
Mitti Jain C.S.	Company Secretary and Compliance Officer
Varsha Pravin Joshi	Chief Financial Officer
Anil Fargade	Senior Accounts Officer
Sunil Sitale	Manager of Human Resources and Admin